Mesa Laboratories, Inc.
MLAB
$98.67
$2.312.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.12% | 8.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.12% | 8.66% | |||
| Cost of Revenue | 2.76% | 5.30% | |||
| Gross Profit | -3.38% | 10.71% | |||
| SG&A Expenses | 10.11% | 5.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.32% | 5.92% | |||
| Operating Income | -74.58% | 45.86% | |||
| Income Before Tax | 120.79% | -158.16% | |||
| Income Tax Expenses | 1,500.18% | -240.89% | |||
| Earnings from Continuing Operations | -324.46% | -148.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -324.46% | -148.89% | |||
| EBIT | -74.58% | 45.86% | |||
| EBITDA | -20.49% | 12.42% | |||
| EPS Basic | -323.71% | -148.74% | |||
| Normalized Basic EPS | 120.77% | -151.81% | |||
| EPS Diluted | -321.94% | -149.21% | |||
| Normalized Diluted EPS | 120.77% | -152.37% | |||
| Average Basic Shares Outstanding | 0.18% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.18% | -0.77% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.76% | -3.05% | |||